These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 25267471)

  • 21. Impact of propylthiouracil on quality of life in psoriasis patients.
    Malligarjunan H; Dayalan H; Gnanaraj P; Elango T; Subramanian S
    Indian J Med Sci; 2011 Aug; 65(8):331-6. PubMed ID: 23442529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of orally administered antithyroid thioureylenes on PCNA and P53 expression in psoriatic lesions.
    Elias AN; Barr RJ; Rohan MK; Dangaran K
    Int J Dermatol; 1995 Apr; 34(4):280-3. PubMed ID: 7790147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infliximab restores the balance between pro- and anti-apoptotic proteins in regressing psoriatic lesions.
    Kokolakis G; Giannikaki E; Stathopoulos E; Avramidis G; Tosca AD; Krüger-Krasagakis S
    Br J Dermatol; 2012 Mar; 166(3):491-7. PubMed ID: 21985184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased beta 2-adrenergic receptor-mRNA and loricrin-mRNA, and increased involucrin-mRNA transcripts in psoriatic epidermis: analysis by reverse transcription-polymerase chain reaction.
    Takahashi H; Kinouchi M; Tamura T; Iizuka H
    Br J Dermatol; 1996 Jun; 134(6):1065-9. PubMed ID: 8763426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced apoptosis in psoriatic plaques after treatment with propylthiouracil.
    Elias AN; Barr RJ
    Eur J Dermatol; 2007; 17(4):353-4. PubMed ID: 17540660
    [No Abstract]   [Full Text] [Related]  

  • 26. Differences in involucrin immunolabeling within cornified cell envelopes in normal and psoriatic epidermis.
    Ishida-Yamamoto A; Iizuka H
    J Invest Dermatol; 1995 Mar; 104(3):391-5. PubMed ID: 7861008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propylthiouracil before 131I therapy of hyperthyroid diseases: effect on cure rate evaluated by a randomized clinical trial.
    Bonnema SJ; Bennedbaek FN; Veje A; Marving J; Hegedüs L
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4439-44. PubMed ID: 15356044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of propylthiouracil and methimazole on serum levels of interleukin-2 receptors in patients with psoriasis.
    Elias AN; Goodman MM; Rohan MK
    Int J Dermatol; 1993 Jul; 32(7):537-40. PubMed ID: 8340196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Up-regulation of Notch-1 in psoriasis: an immunohistochemical study.
    Abdou AG; Maraee AH; Sharaf A; Elnaidany NF
    Ann Diagn Pathol; 2012 Jun; 16(3):177-84. PubMed ID: 22197545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Graves' patients treated with propylthiouracil.
    Cin MO; Gursoy A; Morris Y; Aydintug OT; Kamel N; Gullu S
    Int J Clin Pract; 2009 Feb; 63(2):299-302. PubMed ID: 19196368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose oral propylthiouracil in the treatment of plaque psoriasis.
    Elias AR; Barr RJ
    Int J Dermatol; 1995 Jul; 34(7):519-20. PubMed ID: 7591425
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
    Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
    Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Programmed cell death of keratinocytes in infliximab-treated plaque-type psoriasis.
    Krüger-Krasagakis S; Galanopoulos VK; Giannikaki L; Stefanidou M; Tosca AD
    Br J Dermatol; 2006 Mar; 154(3):460-6. PubMed ID: 16445776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of antiapoptotic protein c-FLIP is upregulated in psoriasis epidermis.
    Yang J; Li Y; Liu YQ; Long JW; Tian F; Dong J; Shen GX; Tu YT; Tao J
    Eur J Dermatol; 2009; 19(1):29-33. PubMed ID: 19059832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Palmar skin lesions reversed by propylthiouracil therapy.
    Malani AK
    Am J Ther; 2006; 13(4):376-7. PubMed ID: 16858175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ustekinumab improves psoriasis-related gene expression in noninvolved psoriatic skin without inhibition of the antimicrobial response.
    Baerveldt EM; Onderdijk AJ; Kurek D; Kant M; Florencia EF; Ijpma AS; van der Spek PJ; Bastiaans J; Jansen PA; van Kilsdonk JW; Laman JD; Prens EP
    Br J Dermatol; 2013 May; 168(5):990-8. PubMed ID: 23278632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Precocious appearance of involucrin and epidermal transglutaminase during differentiation of psoriatic skin.
    Bernard BA; Reano A; Darmon YM; Thivolet J
    Br J Dermatol; 1986 Mar; 114(3):279-83. PubMed ID: 2869777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis.
    Goedkoop AY; Kraan MC; Teunissen MB; Picavet DI; de Rie MA; Bos JD; Tak PP
    Ann Rheum Dis; 2004 Jul; 63(7):769-73. PubMed ID: 15194570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation and altered spatial pattern of caveolin-1 in chronic plaque psoriasis.
    Campbell L; Laidler P; Watson RE; Kirby B; Griffiths CE; Gumbleton M
    Br J Dermatol; 2002 Oct; 147(4):701-9. PubMed ID: 12366416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.